穿支动脉粥样硬化疾病临床研究进展  

Advances in clinical research for branch atheromatous disease

作　　者：张增雨 金芃芃 余波 杨化兰 涂志兰 李超 胡梦婷 侯双兴 Zhang Zengyu;Jin Pengpeng;Yu Bo;Yang Hualan;Tu Zhilan;Li Chao;Hu Mengting;Hou Shuangxing(Department of Neurology,Pudong Hospital,Fudan University,Shanghai 201399,China)

机构地区：[1]复旦大学附属浦东医院神经内科,上海201399 [2]复旦大学附属浦东医院科创中心,上海201399 [3]复旦大学附属浦东医院血管外科,上海201399

出　　处：《中国脑血管病杂志》2021年第6期428-432,共5页Chinese Journal of Cerebrovascular Diseases

基　　金：上海市浦东新区卫生和计划生育委员会重点学科群建设资助(PWZxq2017-09);上海市浦东医院重点学科项目(Zdxk2020-09)。

摘　　要：穿支动脉粥样硬化疾病(BAD)是导致急性孤立性皮质下梗死的重要原因,且BAD相关卒中患者易出现症状波动及早期进展,导致预后不佳,临床上需要早期识别并进行干预从而改善预后。本文就BAD的临床诊断、常见危险因素、影像学、生物学标志物以及治疗策略进行综述,以期提高临床医师对BAD的认识。Branch atheromatous disease(BAD)is a critical cause of acute single subcortical infarction.Patients with BAD-related stroke are prone to having fluctuated symptoms and early progression and poor prognosis.Early clinical identification and intervention are needed to improve the prognosis.In this article,the clinical diagnosis,common risk factors,imaging,biological markers and treatment strategies of BAD were reviewed in order to improve clinicians′understanding of BAD.

关 键 词：穿支动脉粥样硬化疾病 影像学 生物学标志物 治疗策略 综述 

分 类 号：R543.5[医药卫生—心血管疾病]